Literature DB >> 33493657

Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects.

Qichao Hu1, Wenwen Zhang1, Zhao Wu1, Xin Tian1, Junbao Xiang1, Longxuan Li1, Zhihao Li1, Xi Peng1, Shizhang Wei2, Xiao Ma3, Yanling Zhao4.   

Abstract

With the development of high-throughput screening and bioinformatics technology, natural products with a range of pharmacological targets in multiple diseases have become important sources of new drug discovery. These compounds are derived from various plants, including the dried root of Scutellaria baicalensis Georgi, which is often used as a traditional Chinese herb named Huangqin, a popular medication used for thousands of years in China. Many studies have shown that baicalin, an extract from Scutellaria baicalensis Georgi, exerts various protective effects on liver and gut diseases. Baicalin plays a therapeutic role mainly by mediating downstream apoptosis and immune response pathways induced by upstream oxidative stress and inflammation. During oxidative stress regulation, PI3K/Akt/NRF2, Keap-1, NF-κB and HO-1 are key factors associated with the healing effects of baicalin on NAFLD/NASH, ulcerative colitis and cholestasis. In the inflammatory response, IL-6, IL-1β, TNF-α, MIP-2 and MIP-1α are involved in the alleviation of NAFLD/NASH, cholestasis and liver fibrosis by baicalin, as are TGF-β1/Smads, STAT3 and NF-κB. Regarding the apoptosis pathway, Bax, Bcl-2, Caspase-3 and Caspase-9 are key factors related to the suppression of hepatocellular carcinoma and attenuation of liver injury and colorectal cancer. In addition to immune regulation, PD-1/PDL-1 and TLR4-NF-κB are correlated with the alleviation of hepatocellular carcinoma, ulcerative colitis and colorectal cancer by baicalin. Moreover, baicalin regulates intestinal flora by promoting the production of SCFAs. Furthermore, BA is involved in the interactions of the liver-gut axis by regulating TGR5, FXR, bile acids and the microbiota. In general, a comprehensive analysis of this natural compound was conducted to determine the mechanism by which it regulates bile acid metabolism, the intestinal flora and related signaling pathways, providing new insights into the pharmacological effects of baicalin. The mechanism linking the liver and gut systems needs to be elucidated to draw attention to its great clinical importance.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Baicalin; Bile acid; Intestinal flora; Liver-gut system; Pharmacological basis

Mesh:

Substances:

Year:  2021        PMID: 33493657     DOI: 10.1016/j.phrs.2021.105444

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  18 in total

1.  Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics.

Authors:  Yong-Jun Cao; Han-Zhou Li; Jie Zhao; Yu-Meng Sun; Xiao-Wen Jin; Shu-Quan Lv; Jun-Yu Luo; Xi-Xing Fang; Wei-Bo Wen; Jia-Bao Liao
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-08       Impact factor: 2.650

2.  Yinzhihuang oral liquid protects against non-alcoholic steatohepatitis via modulation of the gut-liver axis in mice.

Authors:  Shuyu Li; Fangyuan Chen; Yanting Zou; Liuxin Ning; Guangcong Zhang; Shuncai Zhang; Qunyan Yao
Journal:  Ann Transl Med       Date:  2022-06

Review 3.  Updated Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of Natural Product Geniposide.

Authors:  Liping Liu; Qin Wu; Yuping Chen; Guoxiang Gu; Runan Gao; Bo Peng; Yue Wang; Anbang Li; Jipeng Guo; Xinru Xu; Xiaochen Shao; Lingxing Li; Ya Shen; Jihu Sun
Journal:  Molecules       Date:  2022-05-21       Impact factor: 4.927

4.  Baicalin relieves Mycoplasma pneumoniae infection‑induced lung injury through regulating microRNA‑221 to inhibit the TLR4/NF‑κB signaling pathway.

Authors:  Han Zhang; Xiang Li; Juan Wang; Qi Cheng; Yunxiao Shang; Guizhen Wang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

5.  Protective effect of baicalin against arsenic trioxide-induced acute hepatic injury in mice through JAK2/STAT3 signaling pathway.

Authors:  Qianqian He; Xiaoqi Sun; Muqing Zhang; Li Chu; Yang Zhao; Yongchao Wu; Jianping Zhang; Xue Han; Shengjiang Guan; Chao Ding
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

Review 6.  Pharmacological Effects and Molecular Protective Mechanisms of Astragalus Polysaccharides on Nonalcoholic Fatty Liver Disease.

Authors:  Jing Zhang; Quansheng Feng
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

7.  Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia.

Authors:  Xinxin Li; Shuling Li; Chun Ma; Tieshu Li; Lihua Yang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 8.  Flavonoids on diabetic nephropathy: advances and therapeutic opportunities.

Authors:  Qichao Hu; Caiyan Qu; Xiaolin Xiao; Wenwen Zhang; Yinxiao Jiang; Zhao Wu; Dan Song; Xi Peng; Xiao Ma; YanLing Zhao
Journal:  Chin Med       Date:  2021-08-07       Impact factor: 5.455

Review 9.  Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives.

Authors:  Xianmin Dai; Jiayi Feng; Yi Chen; Si Huang; Xiaofei Shi; Xia Liu; Yang Sun
Journal:  Chin Med       Date:  2021-08-03       Impact factor: 5.455

10.  Supplementation With Chinese Medicinal Plant Extracts From Lonicera hypoglauca and Scutellaria baicalensis Mitigates Colonic Inflammation by Regulating Oxidative Stress and Gut Microbiota in a Colitis Mouse Model.

Authors:  Fan Wan; Mengyu Wang; Ruqing Zhong; Liang Chen; Hui Han; Lei Liu; Yong Zhao; Huiyuan Lv; Fujiang Hou; Bao Yi; Hongfu Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-01-04       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.